Medicinal product name Aerinaze
Pharmaceutical form Modified-release tablet
Strength 2.5 mg/120 mg 
Information from the MAH on shortages Not notified
Legal status Rx Prescription (Pr.III)
 Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
ATC code R01BA52 Nasal preparations

Medicinal products (1)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N4
(2,5/120 mg)
PVC/PCTFE/AL blister    EU/1/07/399/002  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website

Registration information

Marketing authorisation No. EU/1/07/399/002
Date of authorisation Jul 30, 2007
Marketing authorisation holder, country N.V. Organon, Netherlands